Abstract
In the title compound, C7H8N4S, the non-H atoms of the pyrazolo[3,4-d]pyrimidine ring system and the methylsulfanyl group lie on a crystallographic mirror plane. In the crystal, molecules are linked via a number of π–π interactions [centroid–centroid distances vary from 3.452 (7) to 3.6062 (8) Å], forming a three-dimensional structure.
Keywords: crystal structure; 1H-pyrazolo[3,4-d]pyrimidine; pharmacological and biochemical properties; π–π interactions
Related literature
For similar compounds, see: El Fal et al. (2013 ▶, 2014a
▶,b
▶); Ouzidan et al. (2011 ▶). For pharmacological and biochemical properties of pyrazolo[3,4-d]pyrimidine-4(5H)-thione derivatives, see: Chauhan & Kumar (2013 ▶); Venkatesan et al. (2014 ▶); Rashad et al. (2011 ▶).
Experimental
Crystal data
C7H8N4S
M r = 180.23
Orthorhombic,
a = 7.9309 (14) Å
b = 15.335 (3) Å
c = 6.7158 (12) Å
V = 816.8 (3) Å3
Z = 4
Mo Kα radiation
μ = 0.34 mm−1
T = 296 K
0.37 × 0.28 × 0.19 mm
Data collection
Bruker X8 APEX diffractometer
Absorption correction: multi-scan (SADABS; Bruker, 2009 ▶) T min = 0.637, T max = 0.746
2970 measured reflections
1227 independent reflections
1017 reflections with I > 2σ(I)
R int = 0.017
Refinement
R[F 2 > 2σ(F 2)] = 0.042
wR(F 2) = 0.129
S = 1.09
1227 reflections
73 parameters
H-atom parameters constrained
Δρmax = 0.44 e Å−3
Δρmin = −0.29 e Å−3
Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: SAINT (Bruker, 2009 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012 ▶); software used to prepare material for publication: PLATON (Spek, 2009 ▶) and publCIF (Westrip, 2010 ▶).
Supplementary Material
Crystal structure: contains datablock(s) I. DOI: 10.1107/S1600536814025239/tk5348sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536814025239/tk5348Isup2.hkl
Supporting information file. DOI: 10.1107/S1600536814025239/tk5348Isup3.cml
. DOI: 10.1107/S1600536814025239/tk5348fig1.tif
Molecular structure of the title compound with the atom-labelling scheme. Displacement ellipsoids are drawn at the 50% probability level. H atoms are represented as small circles.
CCDC reference: 1034638
Additional supporting information: crystallographic information; 3D view; checkCIF report
Acknowledgments
The authors thank the Unit of Support for Technical and Scientific Research (UATRS, CNRST) for the X-ray measurements.
supplementary crystallographic information
S1. Structural commentary
Synthesis of 1H-pyrazolo [3,4-d] pyrimidine-4-thiol derivatives has received considerable attention due to their biological activity especially as antimicrobial (Chauhan et al., 2013), antitubercular (Venkatesan et al., 2014) and anticancer (Rashad et al., 2011) agents. During the search for new antibacterial agents synthesis, some 1H-pyrazolo[3,4-d] pyrimidine-4-thiol derivatives were prepared (El Fal et al., 2013, 2014a, 2014b; Ouzidan et al., 2011). These compounds are currently under investigation for possible biological activity.
The molecule of the title compound is build up from two fused five- and six-membered rings linked to methylsulfanyl group. All non hydrogen atoms of the molecule are coplanar as shown in Fig. 1. In the crystal, the molecules are linked together by a number of π–π interactions [centroid–centroid distances vary from 3.452 (7) to 3.6062 (8) Å], forming a three-dimensional structure.
S2. Synthesis and crystallization
To a solution of 1H-pyrazolo [3,4-d] pyrimidine-4-thiol (0.5 g, 3.28 mmol) dissolved in DMF (20 ml) was added iodomethane (0.43 ml, 6.62 mmol), potassium carbonate (0.93 g, 7.1 mmol) and a catalytic amount of tetra-n-butylammonium bromide (0.1 g, 0.4 mmol). The mixture was stirred for 48 h and monitored by thin layer chromatography. The mixture was filtered and the solvent was removed in vacuo. The solid obtained was crystallized from ethanol to give the title compound as orange crystals (yield: 65%).
S3. Refinement
The H atoms were located in a difference map and treated as riding with C—H = 0.93 Å (aromatic) and C—H = 0.96 Å (methyl), and with Uiso(H) = 1.2 Ueq (aromatic) and Uiso(H) = 1.5 Ueq (methyl).
Figures
Fig. 1.
Molecular structure of the title compound with the atom-labelling scheme. Displacement ellipsoids are drawn at the 50% probability level. H atoms are represented as small circles.
Crystal data
| C7H8N4S | F(000) = 376 |
| Mr = 180.23 | Dx = 1.466 Mg m−3 |
| Orthorhombic, Pbcm | Mo Kα radiation, λ = 0.71073 Å |
| Hall symbol: -P 2c 2b | Cell parameters from 1227 reflections |
| a = 7.9309 (14) Å | θ = 2.6–29.6° |
| b = 15.335 (3) Å | µ = 0.34 mm−1 |
| c = 6.7158 (12) Å | T = 296 K |
| V = 816.8 (3) Å3 | Block, orange |
| Z = 4 | 0.37 × 0.28 × 0.19 mm |
Data collection
| Bruker X8 APEX diffractometer | 1227 independent reflections |
| Radiation source: fine-focus sealed tube | 1017 reflections with I > 2σ(I) |
| Graphite monochromator | Rint = 0.017 |
| φ and ω scans | θmax = 29.6°, θmin = 2.6° |
| Absorption correction: multi-scan (SADABS; Bruker, 2009) | h = −10→4 |
| Tmin = 0.637, Tmax = 0.746 | k = −21→19 |
| 2970 measured reflections | l = −3→9 |
Refinement
| Refinement on F2 | Primary atom site location: structure-invariant direct methods |
| Least-squares matrix: full | Secondary atom site location: difference Fourier map |
| R[F2 > 2σ(F2)] = 0.042 | Hydrogen site location: inferred from neighbouring sites |
| wR(F2) = 0.129 | H-atom parameters constrained |
| S = 1.09 | w = 1/[σ2(Fo2) + (0.0694P)2 + 0.3181P] where P = (Fo2 + 2Fc2)/3 |
| 1227 reflections | (Δ/σ)max < 0.001 |
| 73 parameters | Δρmax = 0.44 e Å−3 |
| 0 restraints | Δρmin = −0.29 e Å−3 |
Special details
| Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
| Refinement. Refinement of F2 against all reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on all data will be even larger. |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
| x | y | z | Uiso*/Ueq | ||
| C1 | 0.5519 (3) | 0.06804 (13) | 0.2500 | 0.0393 (5) | |
| H1 | 0.4928 | 0.0156 | 0.2500 | 0.047* | |
| C2 | 0.5516 (3) | 0.21199 (12) | 0.2500 | 0.0279 (4) | |
| C3 | 0.7675 (3) | 0.30515 (13) | 0.2500 | 0.0322 (4) | |
| H3 | 0.8763 | 0.3277 | 0.2500 | 0.039* | |
| C4 | 0.7284 (2) | 0.21512 (11) | 0.2500 | 0.0264 (4) | |
| C5 | 0.8115 (3) | 0.13396 (11) | 0.2500 | 0.0285 (4) | |
| C6 | 0.3247 (3) | 0.32714 (15) | 0.2500 | 0.0450 (6) | |
| H6A | 0.3121 | 0.3658 | 0.1386 | 0.068* | |
| H6B | 0.2414 | 0.2818 | 0.2500 | 0.068* | |
| C7 | 1.0858 (3) | 0.02097 (16) | 0.2500 | 0.0483 (6) | |
| H7A | 0.9865 | −0.0148 | 0.2500 | 0.072* | |
| H7B | 1.1499 | 0.0095 | 0.1316 | 0.072* | |
| N1 | 0.7221 (2) | 0.06053 (10) | 0.2500 | 0.0348 (4) | |
| N2 | 0.4577 (2) | 0.13910 (11) | 0.2500 | 0.0369 (4) | |
| N3 | 0.4970 (2) | 0.29563 (11) | 0.2500 | 0.0323 (4) | |
| N4 | 0.6289 (3) | 0.35277 (10) | 0.2500 | 0.0349 (4) | |
| S1 | 1.03110 (7) | 0.13414 (4) | 0.2500 | 0.0447 (2) |
Atomic displacement parameters (Å2)
| U11 | U22 | U33 | U12 | U13 | U23 | |
| C1 | 0.0316 (10) | 0.0218 (9) | 0.0644 (15) | −0.0024 (7) | 0.000 | 0.000 |
| C2 | 0.0294 (9) | 0.0221 (8) | 0.0321 (9) | 0.0016 (7) | 0.000 | 0.000 |
| C3 | 0.0301 (10) | 0.0230 (8) | 0.0434 (11) | −0.0032 (7) | 0.000 | 0.000 |
| C4 | 0.0280 (9) | 0.0216 (8) | 0.0295 (9) | −0.0008 (6) | 0.000 | 0.000 |
| C5 | 0.0295 (9) | 0.0232 (9) | 0.0329 (9) | 0.0005 (7) | 0.000 | 0.000 |
| C6 | 0.0329 (11) | 0.0330 (11) | 0.0692 (16) | 0.0095 (9) | 0.000 | 0.000 |
| C7 | 0.0376 (12) | 0.0393 (12) | 0.0680 (17) | 0.0119 (10) | 0.000 | 0.000 |
| N1 | 0.0307 (9) | 0.0199 (7) | 0.0536 (11) | 0.0005 (6) | 0.000 | 0.000 |
| N2 | 0.0290 (9) | 0.0250 (9) | 0.0568 (12) | −0.0015 (6) | 0.000 | 0.000 |
| N3 | 0.0318 (8) | 0.0221 (7) | 0.0429 (9) | 0.0024 (6) | 0.000 | 0.000 |
| N4 | 0.0399 (10) | 0.0211 (7) | 0.0439 (10) | −0.0021 (6) | 0.000 | 0.000 |
| S1 | 0.0264 (3) | 0.0316 (3) | 0.0761 (5) | 0.00110 (18) | 0.000 | 0.000 |
Geometric parameters (Å, º)
| C1—N2 | 1.321 (3) | C5—N1 | 1.331 (2) |
| C1—N1 | 1.355 (3) | C5—S1 | 1.741 (2) |
| C1—H1 | 0.9300 | C6—N3 | 1.449 (3) |
| C2—N2 | 1.343 (3) | C6—H6A | 0.9598 |
| C2—N3 | 1.354 (2) | C6—H6B | 0.9599 |
| C2—C4 | 1.403 (3) | C7—S1 | 1.789 (3) |
| C3—N4 | 1.319 (3) | C7—H7A | 0.9600 |
| C3—C4 | 1.415 (2) | C7—H7B | 0.9599 |
| C3—H3 | 0.9300 | N3—N4 | 1.365 (3) |
| C4—C5 | 1.408 (2) | ||
| N2—C1—N1 | 129.3 (2) | C4—C5—S1 | 117.82 (14) |
| N2—C1—H1 | 115.3 | N3—C6—H6A | 107.7 |
| N1—C1—H1 | 115.3 | N3—C6—H6B | 114.1 |
| N2—C2—N3 | 127.68 (18) | H6A—C6—H6B | 112.1 |
| N2—C2—C4 | 125.63 (18) | S1—C7—H7A | 110.8 |
| N3—C2—C4 | 106.69 (17) | S1—C7—H7B | 107.8 |
| N4—C3—C4 | 110.97 (17) | H7A—C7—H7B | 109.3 |
| N4—C3—H3 | 124.5 | C5—N1—C1 | 117.33 (17) |
| C4—C3—H3 | 124.5 | C1—N2—C2 | 111.89 (18) |
| C2—C4—C5 | 115.96 (17) | C2—N3—N4 | 111.29 (17) |
| C2—C4—C3 | 104.60 (16) | C2—N3—C6 | 128.13 (19) |
| C5—C4—C3 | 139.45 (19) | N4—N3—C6 | 120.59 (17) |
| N1—C5—C4 | 119.88 (19) | C3—N4—N3 | 106.45 (16) |
| N1—C5—S1 | 122.30 (14) | C5—S1—C7 | 103.95 (11) |
Footnotes
Supporting information for this paper is available from the IUCr electronic archives (Reference: TK5348).
References
- Bruker (2009). APEX2, SAINT-Plus and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
- Chauhan, M. & Kumar, R. (2013). Bioorg. Med. Chem. 21, 5657–5668. [DOI] [PubMed]
- El Fal, M., Ramli, Y., Essassi, E. M., Saadi, M. & El Ammari, L. (2013). Acta Cryst. E69, o1650. [DOI] [PMC free article] [PubMed]
- El Fal, M., Ramli, Y., Essassi, E. M., Saadi, M. & El Ammari, L. (2014a). Acta Cryst. E70, o1005–o1006. [DOI] [PMC free article] [PubMed]
- El Fal, M., Ramli, Y., Essassi, E. M., Saadi, M. & El Ammari, L. (2014b). Acta Cryst. E70, o1038. [DOI] [PMC free article] [PubMed]
- Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.
- Ouzidan, Y., Essassi, E. M., Luis, S. V., Bolte, M. & El Ammari, L. (2011). Acta Cryst. E67, o1822. [DOI] [PMC free article] [PubMed]
- Rashad, A. E., Mahmoud, A. E. & Ali, M. M. (2011). Eur. J. Med. Chem. 46, 1019–1026. [DOI] [PubMed]
- Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
- Spek, A. L. (2009). Acta Cryst. D65, 148–155. [DOI] [PMC free article] [PubMed]
- Venkatesan, G., Paira, P., Cheong, S. L., Vamsikrishna, K., Federico, S., Klotz, K., Spalluto, G. & Pastorin, G. (2014). Bioorg. Med. Chem. 22, 1751–1765. [DOI] [PubMed]
- Westrip, S. P. (2010). J. Appl. Cryst. 43, 920–925.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Crystal structure: contains datablock(s) I. DOI: 10.1107/S1600536814025239/tk5348sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536814025239/tk5348Isup2.hkl
Supporting information file. DOI: 10.1107/S1600536814025239/tk5348Isup3.cml
. DOI: 10.1107/S1600536814025239/tk5348fig1.tif
Molecular structure of the title compound with the atom-labelling scheme. Displacement ellipsoids are drawn at the 50% probability level. H atoms are represented as small circles.
CCDC reference: 1034638
Additional supporting information: crystallographic information; 3D view; checkCIF report

